Filing Details
- Accession Number:
- 0001225208-17-002835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-10 18:23:28
- Reporting Period:
- 2017-02-08
- Filing Date:
- 2017-02-10
- Accepted Time:
- 2017-02-10 18:23:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453458 | M Sharon Luboff | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Group Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-08 | 8,223 | $0.00 | 32,061 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-02-08 | 2,795 | $0.00 | 34,856 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-02-08 | 2,090 | $235.49 | 36,946 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-02-08 | 895 | $164.84 | 37,841 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-02-08 | 3,819 | $236.68 | 34,022 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-02-09 | 5,801 | $239.59 | 28,221 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 69 | Indirect | 401(k) Plan |
Footnotes
- Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Includes 1.349 shares acquired under the Company's Employee Stock Purchase Plan from November 8, 2016 to February 6, 2017.
- Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019.
- Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
- Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $239.30 to $239.85. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Includes 0.055 shares acquired under the Company's 401(k) Plan from November 5, 2016 to February 3, 2017.
Billionaire Hedge Funds
